1974-2014: Reflections on the evolution of clinical pharmacology in the past 40 years and a message to our readers.
作者信息
Ritter James M
机构信息
Department of Clinical Pharmacology, St Thomas's Hospital, London, UK; Quintiles (London), Guy's Hospital, London, UK.
出版信息
Br J Clin Pharmacol. 2014 Jan;77(1):1-4. doi: 10.1111/bcp.12279.
Abstract
摘要
相似文献
1
1974-2014: Reflections on the evolution of clinical pharmacology in the past 40 years and a message to our readers.1974 - 2014：对过去40年临床药理学发展的回顾及致读者的寄语
Br J Clin Pharmacol. 2014 Jan;77(1):1-4. doi: 10.1111/bcp.12279.
2
Clinical Pharmacology Regulatory Sciences in Drug Development and Precision Medicine: Current Status and Emerging Trends.药物研发与精准医学中的临床药理学监管科学：现状与新兴趋势。
AAPS J. 2021 Apr 12;23(3):54. doi: 10.1208/s12248-021-00563-3.
3
The Future of Precision Medicine.精准医学的未来。
Clin Pharmacol Ther. 2019 Nov;106(5):903-906. doi: 10.1002/cpt.1622.
4
"Precision" drug development?精准药物研发？
Clin Pharmacol Ther. 2016 Feb;99(2):152-4. doi: 10.1002/cpt.255. Epub 2015 Nov 20.
5
Spatiotemporal molecular medicine: A new era of clinical and translational medicine.时空分子医学：临床与转化医学的新时代。
Clin Transl Med. 2021 Jan;11(1):e294. doi: 10.1002/ctm2.294.
6
Cancer clinical trials--do we need a new algorithm in the age of stratified medicine?癌症临床试验——在分层医学时代，我们是否需要一种新的算法？
Oncologist. 2013 Jun;18(6):651-2. doi: 10.1634/theoncologist.2013-0190.
7
Evidence needs to be translated, whether or not it is complete.证据需要被翻译，无论其是否完整。
JAMA Neurol. 2014 Feb;71(2):137-8. doi: 10.1001/jamaneurol.2013.5376.
8
[Russian Academy of Medical Sciences: basic research--scientific basis of public health].
Vestn Ross Akad Med Nauk. 2011(2):4-14.
9
Precision oncology in metastatic colorectal cancer - from biology to medicine.精准肿瘤学在转移性结直肠癌中的应用——从生物学到医学。
Nat Rev Clin Oncol. 2021 Aug;18(8):506-525. doi: 10.1038/s41571-021-00495-z. Epub 2021 Apr 16.
10
New challenges in translational medicine: transforming the advancement of science into cures. Preface.转化医学中的新挑战：将科学进步转化为治疗方法。前言。
Ann Ist Super Sanita. 2011;47(1):5-7. doi: 10.4415/ANN_11_01_02.
本文引用的文献
1
Effect of an RNA interference drug on the synthesis of proprotein convertase subtilisin/kexin type 9 (PCSK9) and the concentration of serum LDL cholesterol in healthy volunteers: a randomised, single-blind, placebo-controlled, phase 1 trial.在健康志愿者中，一种 RNA 干扰药物对前蛋白转化酶枯草溶菌素/柯萨奇蛋白酶 9（PCSK9）合成和血清 LDL 胆固醇浓度的影响：一项随机、单盲、安慰剂对照、1 期临床试验。
Lancet. 2014 Jan 4;383(9911):60-68. doi: 10.1016/S0140-6736(13)61914-5. Epub 2013 Oct 3.
2
Progress with the polypill?复方制剂有进展吗？
JAMA. 2013 Sep 4;310(9):910-1. doi: 10.1001/jama.2013.277066.
3
Safety and efficacy of RNAi therapy for transthyretin amyloidosis.RNAi 疗法治疗转甲状腺素淀粉样变性的安全性和有效性。
N Engl J Med. 2013 Aug 29;369(9):819-29. doi: 10.1056/NEJMoa1208760.
4
Trastuzumab emtansine for HER2-positive advanced breast cancer.曲妥珠单抗-美坦新偶联物用于治疗人表皮生长因子受体 2 阳性的晚期乳腺癌。
N Engl J Med. 2012 Nov 8;367(19):1783-91. doi: 10.1056/NEJMoa1209124. Epub 2012 Oct 1.
5
Prescribing aids for gentamicin.庆大霉素的处方辅助工具。
Br J Clin Pharmacol. 1974 Feb;1(1):45-50. doi: 10.1111/j.1365-2125.1974.tb00205.x.
6
Evidence-based mechanistic reasoning.基于证据的机制推理。
J R Soc Med. 2010 Nov;103(11):433-41. doi: 10.1258/jrsm.2010.100146.
7
Looking back: editors' pick of 2008.回首往昔：2008年编辑推荐
Br J Clin Pharmacol. 2009 Jan;67(1):1-4. doi: 10.1111/j.1365-2125.2008.03354.x.
8
Antisense oligonucleotide directed to human apolipoprotein B-100 reduces lipoprotein(a) levels and oxidized phospholipids on human apolipoprotein B-100 particles in lipoprotein(a) transgenic mice.针对人载脂蛋白B-100的反义寡核苷酸可降低载脂蛋白(a)转基因小鼠中载脂蛋白(a)颗粒上的载脂蛋白(a)水平和氧化磷脂。
Circulation. 2008 Aug 12;118(7):743-53. doi: 10.1161/CIRCULATIONAHA.108.786822. Epub 2008 Jul 28.
9
Clinical pharmacology--providing tools and expertise for translational medicine.临床药理学——为转化医学提供工具和专业知识。
Br J Clin Pharmacol. 2008 Feb;65(2):154-7. doi: 10.1111/j.1365-2125.2008.03101.x.
10
The pitfalls in the development of biologic therapy.生物疗法开发中的陷阱。
Nat Clin Pract Rheumatol. 2007 Jan;3(1):1. doi: 10.1038/ncprheum0373.
Zotero 插件